Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable increase in the risk for this disease after menopause and typically develop coronary heart disease several years ...

Diastolic dysfunction is one important causal factor for heart failure with preserved ejection fraction, yet the metabolic signature associated with this subclinical phenotype remains unknown. The ...

BACKGROUND: Desmosomal gene variants (DGVs) have been associated with a diverse spectrum of phenotypic manifestations within ...

Catheter ablation as first-line therapy for ventricular tachycardia (VT) at the time of implantable cardioverter defibrillator (ICD) implantation has not been adopted into clinical guidelines. Also, ...

9. Myocardial Infarction Associated With Percutaneous Coronary Intervention (Type 4a Myocardial Infarction) e629 10. Stent/Scaffold Thrombosis Associated With Percutaneous Coronary Intervention (Type ...

Sedentary behavior and physical inactivity are among the leading modifiable risk factors worldwide for cardiovascular disease and all-cause mortality. The promotion of physical activity and exercise ...

Pulmonary hypertension (PH) attributable to left heart disease (LHD) is believed to be the most common form of PH and is strongly associated with increased mortality and morbidity in this patient ...

Stroke prevention is central to the management of patients with AF. For many years, the use of oral anticoagulant therapy with warfarin, described as a vitamin K antagonist (VKA), has been the ...

Many patients after stroke are found to have elevated serum creatine kinase (CK). This study aimed to investigate the associations between serum CK levels and clinical outcomes in patients with acute ...

The launch of Circulation: Cardiovascular Quality and Outcomes occurs during a time in which the healthcare system is simultaneously achieving its greatest triumphs and facing its most daunting ...

Table 1 reflects recommendations that are substantially revised from the 2020 Hypertrophic Cardiomyopathy Guidelines or were drafted as new recommendations in the 2024 Hypertrophic Cardiomyopathy ...